Physician profile
Jacquelyn Webster
NPI 1124181722
$1,966.59
in general payments reported to CMS, 2019-2025
15 companies · $988 in 2025
The $988 reported for 2025 was more than what 96% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $167 · 2023: $383 · 2024: $206 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $467.53 | 2025 | |
| Hologic Sales and Service, LLC | $260.63 | 2024-2025 | Aptima |
| Astellas Pharma US INC | $196.62 | 2022-2023 | Veozah |
| Exeltis, USA INC. | $141.81 | 2023 | Slynd |
| Pfizer INC. | $137.58 | 2022-2024 | |
| Gilead Sciences, INC. | $130.05 | 2025 | Epclusa |
| Astrazeneca Pharmaceuticals Lp | $121.81 | 2025 | Fasenra |
| Regeneron Healthcare Solutions, INC. | $117.92 | 2023 | Dupixent |
| Genentech USA, INC. | $89.13 | 2021 | |
| Glaxosmithkline, LLC. | $81.79 | 2022 | |
| Mayne Pharma Commercial LLC | $65.92 | 2025 | |
| Merck Sharp & Dohme LLC | $61.88 | 2021 | |
| Seagen INC. | $51.27 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.97 | 2025 | |
| Janssen Biotech, INC. | $19.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Webster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.